APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Gabexate Mesylate for Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Gabexate Mesylate for Injection Industry Growth and Trends Forecast to 2032

Report ID 173993760129 December 202593 pages

Choose your research edition.

Industry ResearchGabexate Mesylate for Injection Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Gabexate Mesylate for Injection Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Gabexate Mesylate for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gabexate Mesylate for Injection Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Gabexate Mesylate for Injection Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Gabexate Mesylate for Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Gabexate Mesylate for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Gabexate Mesylate for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gabexate Mesylate for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gabexate Mesylate for Injection include Chongqing Pharscin Pharmaceutical Co., Ltd., Shanxi Pude Pharmaceutical, Medisan, Emeishan Tonghui Pharmaceutical and Chengdu Tiantai Mount Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Gabexate Mesylate for Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Gabexate Mesylate for Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gabexate Mesylate for Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gabexate Mesylate for Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Gabexate Mesylate for Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Gabexate Mesylate for Injection Market by Company

Chongqing Pharscin Pharmaceutical Co., Ltd.

Shanxi Pude Pharmaceutical

Medisan

Emeishan Tonghui Pharmaceutical

Chengdu Tiantai Mount Pharmaceutical

Gabexate Mesylate for Injection Segment by Type

120mg

160mg

40mg

80mg

Gabexate Mesylate for Injection Segment by Application

Hospital Pharmacy

Retail Pharmacy

Others

Gabexate Mesylate for Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gabexate Mesylate for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gabexate Mesylate for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gabexate Mesylate for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gabexate Mesylate for Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Gabexate Mesylate for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 120mg Table 2. Major Company of 160mg Table 3. Major Company of 40mg Table 4. Major Company of 80mg Table 5. Global Gabexate Mesylate for Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Gabexate Mesylate for Injection Sales by Type (2021-2026) & (K Units) Table 7. Global Gabexate Mesylate for Injection Sales Market Share in Volume by Type (2021-2026) Table 8. Global Gabexate Mesylate for Injection Sales by Type (2021-2026) & (US$ Million) Table 9. Global Gabexate Mesylate for Injection Sales Market Share in Value by Type (2021-2026) Table 10. Global Gabexate Mesylate for Injection Price by Type (2021-2026) & (US$/Unit) Table 11. Global Gabexate Mesylate for Injection Sales by Type (2027-2032) & (K Units) Table 12. Global Gabexate Mesylate for Injection Sales Market Share in Volume by Type (2027-2032) Table 13. Global Gabexate Mesylate for Injection Sales by Type (2027-2032) & (US$ Million) Table 14. Global Gabexate Mesylate for Injection Sales Market Share in Value by Type (2027-2032) Table 15. Global Gabexate Mesylate for Injection Price by Type (2027-2032) & (US$/Unit) Table 16. North America Gabexate Mesylate for Injection Sales by Type (2021-2026) & (K Units) Table 17. North America Gabexate Mesylate for Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Gabexate Mesylate for Injection Sales by Type (2021-2026) & (K Units) Table 19. Europe Gabexate Mesylate for Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Gabexate Mesylate for Injection Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Gabexate Mesylate for Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Gabexate Mesylate for Injection Sales by Type (2021-2026) & (K Units) Table 23. Latin America Gabexate Mesylate for Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Gabexate Mesylate for Injection Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Gabexate Mesylate for Injection Sales by Type (2021-2026) & (US$ Million) Table 26. Gabexate Mesylate for Injection Industry Trends Table 27. Gabexate Mesylate for Injection Industry Drivers Table 28. Gabexate Mesylate for Injection Industry Opportunities and Challenges Table 29. Gabexate Mesylate for Injection Industry Restraints Table 30. Global Gabexate Mesylate for Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Gabexate Mesylate for Injection Revenue Market Share by Company (2021-2026) Table 32. Global Gabexate Mesylate for Injection Sales by Company (2021-2026) & (K Units) Table 33. Global Gabexate Mesylate for Injection Sales Share by Company (2021-2026) Table 34. Global Gabexate Mesylate for Injection Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Gabexate Mesylate for Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Gabexate Mesylate for Injection Major Company Production Sites and Headquarters Table 37. Global Gabexate Mesylate for Injection Company, Product Type & Application Table 38. Global Gabexate Mesylate for Injection Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Gabexate Mesylate for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Gabexate Mesylate for Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Gabexate Mesylate for Injection Sales by Region (2021-2026) & (K Units) Table 43. Global Gabexate Mesylate for Injection Sales Market Share in Volume by Region (2021-2026) Table 44. Global Gabexate Mesylate for Injection Sales by Region (2021-2026) & (US$ Million) Table 45. Global Gabexate Mesylate for Injection Sales Market Share in Value by Region (2021-2026) Table 46. Global Gabexate Mesylate for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Gabexate Mesylate for Injection Sales by Region (2027-2032) & (K Units) Table 48. Global Gabexate Mesylate for Injection Sales Market Share in Volume by Region (2027-2032) Table 49. Global Gabexate Mesylate for Injection Sales by Region (2027-2032) & (US$ Million) Table 50. Global Gabexate Mesylate for Injection Sales Market Share in Value by Region (2027-2032) Table 51. Global Gabexate Mesylate for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Gabexate Mesylate for Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Gabexate Mesylate for Injection Sales by Application (2021-2026) & (K Units) Table 54. Global Gabexate Mesylate for Injection Sales Market Share in Volume by Application (2021-2026) Table 55. Global Gabexate Mesylate for Injection Sales by Application (2021-2026) & (US$ Million) Table 56. Global Gabexate Mesylate for Injection Sales Market Share in Value by Application (2021-2026) Table 57. Global Gabexate Mesylate for Injection Price by Application (2021-2026) & (US$/Unit) Table 58. Global Gabexate Mesylate for Injection Sales by Application (2027-2032) & (K Units) Table 59. Global Gabexate Mesylate for Injection Sales Market Share in Volume by Application (2027-2032) Table 60. Global Gabexate Mesylate for Injection Sales by Application (2027-2032) & (US$ Million) Table 61. Global Gabexate Mesylate for Injection Sales Market Share in Value by Application (2027-2032) Table 62. Global Gabexate Mesylate for Injection Price by Application (2027-2032) & (US$/Unit) Table 63. North America Gabexate Mesylate for Injection Sales by Application (2021-2026) & (K Units) Table 64. North America Gabexate Mesylate for Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Gabexate Mesylate for Injection Sales by Application (2021-2026) & (K Units) Table 66. Europe Gabexate Mesylate for Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Gabexate Mesylate for Injection Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Gabexate Mesylate for Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Gabexate Mesylate for Injection Sales by Application (2021-2026) & (K Units) Table 70. Latin America Gabexate Mesylate for Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Gabexate Mesylate for Injection Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Gabexate Mesylate for Injection Sales by Application (2021-2026) & (US$ Million) Table 73. Chongqing Pharscin Pharmaceutical Co., Ltd. Company Information Table 74. Chongqing Pharscin Pharmaceutical Co., Ltd. Business Overview Table 75. Chongqing Pharscin Pharmaceutical Co., Ltd. Gabexate Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Chongqing Pharscin Pharmaceutical Co., Ltd. Gabexate Mesylate for Injection Product Portfolio Table 77. Chongqing Pharscin Pharmaceutical Co., Ltd. Recent Development Table 78. Shanxi Pude Pharmaceutical Company Information Table 79. Shanxi Pude Pharmaceutical Business Overview Table 80. Shanxi Pude Pharmaceutical Gabexate Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Shanxi Pude Pharmaceutical Gabexate Mesylate for Injection Product Portfolio Table 82. Shanxi Pude Pharmaceutical Recent Development Table 83. Medisan Company Information Table 84. Medisan Business Overview Table 85. Medisan Gabexate Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Medisan Gabexate Mesylate for Injection Product Portfolio Table 87. Medisan Recent Development Table 88. Emeishan Tonghui Pharmaceutical Company Information Table 89. Emeishan Tonghui Pharmaceutical Business Overview Table 90. Emeishan Tonghui Pharmaceutical Gabexate Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Emeishan Tonghui Pharmaceutical Gabexate Mesylate for Injection Product Portfolio Table 92. Emeishan Tonghui Pharmaceutical Recent Development Table 93. Chengdu Tiantai Mount Pharmaceutical Company Information Table 94. Chengdu Tiantai Mount Pharmaceutical Business Overview Table 95. Chengdu Tiantai Mount Pharmaceutical Gabexate Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Chengdu Tiantai Mount Pharmaceutical Gabexate Mesylate for Injection Product Portfolio Table 97. Chengdu Tiantai Mount Pharmaceutical Recent Development Table 98. North America Gabexate Mesylate for Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 99. North America Gabexate Mesylate for Injection Sales by Country (2021-2026) & (K Units) Table 100. North America Gabexate Mesylate for Injection Sales Market Share by Country (2021-2026) Table 101. North America Gabexate Mesylate for Injection Sales Forecast by Country (2027-2032) & (K Units) Table 102. North America Gabexate Mesylate for Injection Sales Market Share Forecast by Country (2027-2032) Table 103. North America Gabexate Mesylate for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Gabexate Mesylate for Injection Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Gabexate Mesylate for Injection Market Share by Country (2021-2026) Table 106. North America Gabexate Mesylate for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Gabexate Mesylate for Injection Market Share Forecast by Country (2027-2032) Table 108. Europe Gabexate Mesylate for Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 109. Europe Gabexate Mesylate for Injection Sales by Country (2021-2026) & (K Units) Table 110. Europe Gabexate Mesylate for Injection Sales Market Share by Country (2021-2026) Table 111. Europe Gabexate Mesylate for Injection Sales Forecast by Country (2027-2032) & (K Units) Table 112. Europe Gabexate Mesylate for Injection Sales Market Share Forecast by Country (2027-2032) Table 113. Europe Gabexate Mesylate for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe Gabexate Mesylate for Injection Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe Gabexate Mesylate for Injection Market Share by Country (2021-2026) Table 116. Europe Gabexate Mesylate for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe Gabexate Mesylate for Injection Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Gabexate Mesylate for Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Gabexate Mesylate for Injection Sales by Country (2021-2026) & (K Units) Table 120. Asia-Pacific Gabexate Mesylate for Injection Sales Market Share by Country (2021-2026) Table 121. Asia-Pacific Gabexate Mesylate for Injection Sales Forecast by Country (2027-2032) & (K Units) Table 122. Asia-Pacific Gabexate Mesylate for Injection Sales Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Gabexate Mesylate for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Gabexate Mesylate for Injection Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Gabexate Mesylate for Injection Market Share by Country (2021-2026) Table 126. Asia-Pacific Gabexate Mesylate for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Gabexate Mesylate for Injection Market Share Forecast by Country (2027-2032) Table 128. Latin America Gabexate Mesylate for Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. Latin America Gabexate Mesylate for Injection Sales by Country (2021-2026) & (K Units) Table 130. Latin America Gabexate Mesylate for Injection Sales Market Share by Country (2021-2026) Table 131. Latin America Gabexate Mesylate for Injection Sales Forecast by Country (2027-2032) & (K Units) Table 132. Latin America Gabexate Mesylate for Injection Sales Market Share Forecast by Country (2027-2032) Table 133. Latin America Gabexate Mesylate for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Gabexate Mesylate for Injection Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Gabexate Mesylate for Injection Market Share by Country (2021-2026) Table 136. Latin America Gabexate Mesylate for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Gabexate Mesylate for Injection Market Share Forecast by Country (2027-2032) Table 138. Middle East and Africa Gabexate Mesylate for Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Middle East and Africa Gabexate Mesylate for Injection Sales by Country (2021-2026) & (K Units) Table 140. Middle East and Africa Gabexate Mesylate for Injection Sales Market Share by Country (2021-2026) Table 141. Middle East and Africa Gabexate Mesylate for Injection Sales Forecast by Country (2027-2032) & (K Units) Table 142. Middle East and Africa Gabexate Mesylate for Injection Sales Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Gabexate Mesylate for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Gabexate Mesylate for Injection Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East and Africa Gabexate Mesylate for Injection Market Share by Country (2021-2026) Table 146. Middle East and Africa Gabexate Mesylate for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Gabexate Mesylate for Injection Market Share Forecast by Country (2027-2032) Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Gabexate Mesylate for Injection Distributors List Table 151. Gabexate Mesylate for Injection Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Gabexate Mesylate for Injection Image Figure 2. Global Gabexate Mesylate for Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gabexate Mesylate for Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Gabexate Mesylate for Injection Sales (2021-2032) & (K Units) Figure 5. 120mg Image Figure 6. Global 120mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 160mg Image Figure 8. Global 160mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. 40mg Image Figure 10. Global 40mg Sales YoY Growth (2021-2032) & (K Units) Figure 11. 80mg Image Figure 12. Global 80mg Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Gabexate Mesylate for Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Gabexate Mesylate for Injection Market Share by Type 2025 VS 2032 Figure 15. North America Gabexate Mesylate for Injection Sales Market Share in Volume by Type in 2025 Figure 16. North America Gabexate Mesylate for Injection Sales Market Share in Value by Type in 2025 Figure 17. Europe Gabexate Mesylate for Injection Sales Market Share in Volume by Type in 2025 Figure 18. Europe Gabexate Mesylate for Injection Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Gabexate Mesylate for Injection Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Gabexate Mesylate for Injection Sales Market Share in Value by Type in 2025 Figure 21. Latin America Gabexate Mesylate for Injection Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Gabexate Mesylate for Injection Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Gabexate Mesylate for Injection Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Gabexate Mesylate for Injection Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Gabexate Mesylate for Injection Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Pharmacy Image Figure 28. Global Hospital Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 29. Retail Pharmacy Image Figure 30. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Gabexate Mesylate for Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Gabexate Mesylate for Injection Market Share by Application 2025 VS 2032 Figure 35. North America Gabexate Mesylate for Injection Sales Market Share in Volume by Application in 2025 Figure 36. North America Gabexate Mesylate for Injection Sales Market Share in Value by Application in 2025 Figure 37. Europe Gabexate Mesylate for Injection Sales Market Share in Volume by Application in 2025 Figure 38. Europe Gabexate Mesylate for Injection Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Gabexate Mesylate for Injection Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Gabexate Mesylate for Injection Sales Market Share in Value by Application in 2025 Figure 41. Latin America Gabexate Mesylate for Injection Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Gabexate Mesylate for Injection Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Gabexate Mesylate for Injection Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Gabexate Mesylate for Injection Sales Market Share in Value by Application in 2025 Figure 45. North America Gabexate Mesylate for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Gabexate Mesylate for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Gabexate Mesylate for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Gabexate Mesylate for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Gabexate Mesylate for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Gabexate Mesylate for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Gabexate Mesylate for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Gabexate Mesylate for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Gabexate Mesylate for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Gabexate Mesylate for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Gabexate Mesylate for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Gabexate Mesylate for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Gabexate Mesylate for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Gabexate Mesylate for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Gabexate Mesylate for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Gabexate Mesylate for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Gabexate Mesylate for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Gabexate Mesylate for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Gabexate Mesylate for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Gabexate Mesylate for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Gabexate Mesylate for Injection Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Gabexate Mesylate for Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 120mg
  • 160mg
  • 40mg
  • 80mg
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
  • Others
Companies covered
  • Chongqing Pharscin Pharmaceutical Co., Ltd.
  • Shanxi Pude Pharmaceutical
  • Medisan
  • Emeishan Tonghui Pharmaceutical
  • Chengdu Tiantai Mount Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gabexate Mesylate for Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Gabexate Mesylate for Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Gabexate Mesylate for Injection Market by Type
  6. 1.3.1 120mg
  7. 1.3.2 160mg
  8. 1.3.3 40mg
  9. 1.3.4 80mg
  10. 1.4 Global Gabexate Mesylate for Injection Market Size by Type
  11. 1.4.1 Global Gabexate Mesylate for Injection Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Gabexate Mesylate for Injection Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Gabexate Mesylate for Injection Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Gabexate Mesylate for Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Gabexate Mesylate for Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Gabexate Mesylate for Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Gabexate Mesylate for Injection Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Gabexate Mesylate for Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Gabexate Mesylate for Injection Industry Trends
  2. 2.2 Gabexate Mesylate for Injection Industry Drivers
  3. 2.3 Gabexate Mesylate for Injection Industry Opportunities and Challenges
  4. 2.4 Gabexate Mesylate for Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Gabexate Mesylate for Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Gabexate Mesylate for Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Gabexate Mesylate for Injection Price (2021-2026)
  4. 3.4 Global Gabexate Mesylate for Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gabexate Mesylate for Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Gabexate Mesylate for Injection Company, Product Type & Application
  7. 3.7 Global Gabexate Mesylate for Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gabexate Mesylate for Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gabexate Mesylate for Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gabexate Mesylate for Injection Tier 1, Tier 2, and Tier 3
4 Gabexate Mesylate for Injection Regional Status and Outlook
  1. 4.1 Global Gabexate Mesylate for Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Gabexate Mesylate for Injection Historic Market Size by Region
  3. 4.2.1 Global Gabexate Mesylate for Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Gabexate Mesylate for Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Gabexate Mesylate for Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Gabexate Mesylate for Injection Forecasted Market Size by Region
  7. 4.3.1 Global Gabexate Mesylate for Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Gabexate Mesylate for Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Gabexate Mesylate for Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Gabexate Mesylate for Injection by Application
  1. 5.1 Gabexate Mesylate for Injection Market by Application
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 Others
  5. 5.2 Global Gabexate Mesylate for Injection Market Size by Application
  6. 5.2.1 Global Gabexate Mesylate for Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Gabexate Mesylate for Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Gabexate Mesylate for Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Gabexate Mesylate for Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Gabexate Mesylate for Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Gabexate Mesylate for Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Gabexate Mesylate for Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Gabexate Mesylate for Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chongqing Pharscin Pharmaceutical Co., Ltd.
  2. 6.1.1 Chongqing Pharscin Pharmaceutical Co., Ltd. Company Information
  3. 6.1.2 Chongqing Pharscin Pharmaceutical Co., Ltd. Business Overview
  4. 6.1.3 Chongqing Pharscin Pharmaceutical Co., Ltd. Gabexate Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chongqing Pharscin Pharmaceutical Co., Ltd. Gabexate Mesylate for Injection Product Portfolio
  6. 6.1.5 Chongqing Pharscin Pharmaceutical Co., Ltd. Recent Developments
  7. 6.2 Shanxi Pude Pharmaceutical
  8. 6.2.1 Shanxi Pude Pharmaceutical Company Information
  9. 6.2.2 Shanxi Pude Pharmaceutical Business Overview
  10. 6.2.3 Shanxi Pude Pharmaceutical Gabexate Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shanxi Pude Pharmaceutical Gabexate Mesylate for Injection Product Portfolio
  12. 6.2.5 Shanxi Pude Pharmaceutical Recent Developments
  13. 6.3 Medisan
  14. 6.3.1 Medisan Company Information
  15. 6.3.2 Medisan Business Overview
  16. 6.3.3 Medisan Gabexate Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Medisan Gabexate Mesylate for Injection Product Portfolio
  18. 6.3.5 Medisan Recent Developments
  19. 6.4 Emeishan Tonghui Pharmaceutical
  20. 6.4.1 Emeishan Tonghui Pharmaceutical Company Information
  21. 6.4.2 Emeishan Tonghui Pharmaceutical Business Overview
  22. 6.4.3 Emeishan Tonghui Pharmaceutical Gabexate Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Emeishan Tonghui Pharmaceutical Gabexate Mesylate for Injection Product Portfolio
  24. 6.4.5 Emeishan Tonghui Pharmaceutical Recent Developments
  25. 6.5 Chengdu Tiantai Mount Pharmaceutical
  26. 6.5.1 Chengdu Tiantai Mount Pharmaceutical Company Information
  27. 6.5.2 Chengdu Tiantai Mount Pharmaceutical Business Overview
  28. 6.5.3 Chengdu Tiantai Mount Pharmaceutical Gabexate Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Chengdu Tiantai Mount Pharmaceutical Gabexate Mesylate for Injection Product Portfolio
  30. 6.5.5 Chengdu Tiantai Mount Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Gabexate Mesylate for Injection Sales by Country
  2. 7.1.1 North America Gabexate Mesylate for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Gabexate Mesylate for Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Gabexate Mesylate for Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Gabexate Mesylate for Injection Market Size by Country
  6. 7.2.1 North America Gabexate Mesylate for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Gabexate Mesylate for Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Gabexate Mesylate for Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Gabexate Mesylate for Injection Sales by Country
  2. 8.1.1 Europe Gabexate Mesylate for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Gabexate Mesylate for Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Gabexate Mesylate for Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Gabexate Mesylate for Injection Market Size by Country
  6. 8.2.1 Europe Gabexate Mesylate for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Gabexate Mesylate for Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Gabexate Mesylate for Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Gabexate Mesylate for Injection Sales by Country
  2. 9.1.1 Asia-Pacific Gabexate Mesylate for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Gabexate Mesylate for Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Gabexate Mesylate for Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Gabexate Mesylate for Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Gabexate Mesylate for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Gabexate Mesylate for Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Gabexate Mesylate for Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Gabexate Mesylate for Injection Sales by Country
  2. 10.1.1 South America Gabexate Mesylate for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Gabexate Mesylate for Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Gabexate Mesylate for Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Gabexate Mesylate for Injection Market Size by Country
  6. 10.2.1 South America Gabexate Mesylate for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Gabexate Mesylate for Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Gabexate Mesylate for Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Gabexate Mesylate for Injection Sales by Country
  2. 11.1.1 Middle East and Africa Gabexate Mesylate for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Gabexate Mesylate for Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Gabexate Mesylate for Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Gabexate Mesylate for Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Gabexate Mesylate for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Gabexate Mesylate for Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Gabexate Mesylate for Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Gabexate Mesylate for Injection Value Chain Analysis
  2. 12.1.1 Gabexate Mesylate for Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Gabexate Mesylate for Injection Production Mode & Process
  7. 12.2 Gabexate Mesylate for Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Gabexate Mesylate for Injection Distributors
  10. 12.2.3 Gabexate Mesylate for Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst